RayKnowChina Research Map
Shortlist0

How this works

We count public research: papers in PubMed and trials on ClinicalTrials.gov, by the hospital that led them. Every number links to the records behind it.

Research, not qualityPublishing a lot does not mean better care, or that a hospital will accept a particular patient.
Not medical advicePlease discuss anything found here with a doctor before making decisions.
No ranking of peopleWe do not rank doctors or show individual names.

Research data as of 2026-11-08. Official links last checked 2026-11-08.

What the numbers mean
Hospital inclusion for added diseases
One attributable paper, including Chinese-language and 2016–2020 records, or one registered study qualifies. Records with unresolved names or locations await review.
Papers led
English-language PubMed papers whose first or last author lists the hospital as their first affiliation. If an author lists two hospitals, only the first counts.
Share of China's papers
Papers led ÷ all English-language PubMed papers on the disease with a mainland-China author. The headline number on every page.
Share of the world's papers
Papers led ÷ all PubMed papers on the disease, any country, 2021–2025.
Trials led
ClinicalTrials.gov studies whose lead sponsor is the hospital. When the sponsor is only a university or a doctor, the trial goes to a hospital only if it has exactly one site in China, and is marked inferred.
Recruiting
Trials whose ClinicalTrials.gov status is Recruiting on the data date. Check the registry for the current status.
University or health system
Hospitals whose own name carries the university's name, plus papers that name only the university. Provincial and city hospitals with teaching links are not grouped.
Map
Hospital locations are shown at approximate city centres. The base map is Natural Earth (public domain) and is served by this site.
Retracted papers
Papers PubMed marks as Retracted Publication are left out of every count and list: 1190 in this data. Worldwide totals come from PubMed searches and may include a few retracted papers.
Official lists
The “National rare-disease network” and “National medical centre” lines on hospital pages come from official National Health Commission documents (number and date under each page). Hospitals are matched by their full Chinese name only; branch hospitals (e.g. “… Guizhou Hospital”) do not count for the parent; a few renamed hospitals were matched by hand. These are government designations; the site does not rate hospitals by them. On disease pages, “rare-disease catalogue” means China’s first and second national catalogues.
Free full text
Papers that have a free full text in Europe PMC get a “Free full text” link (to Europe PMC). No link does not mean the paper is closed: it may be free on the journal’s site.
Order of lists
Lists are sorted by share of China's papers so the most active appear first. The order is not a rating of care.
Sources
  • Used
    PubMed

    Papers tagged with the disease, 2021–2025, with a China author address. Chinese-language papers counted separately.

  • Used
    ClinicalTrials.gov

    Studies with a site in China, including lead sponsor, study sites and registered status. Follow each record for current status and complete eligibility criteria.

  • Used
    OpenAlex

    Institution IDs for the same papers, plus works on the topic that are not in PubMed.

  • Used
    ROR

    Institution identifiers, name variants and Chinese names.

  • Sample
    ChiCTR

    Chinese trial registry. Ten IgG4-RD records were read for coverage research, outside the site’s statistics.

  • Used
    National Health Commission

    Notices of national diagnosis and treatment guidelines (linked under “Before contacting a hospital” on disease pages); original official lists: national rare-disease network member hospitals (2024), National Center for Neurological Disorders (2021), national and regional children's medical centres (2026), and the first and second national rare-disease catalogues (2018, 2023). Each document opened and read in a browser on 10 November 2026.

  • Used
    Europe PMC

    Whether a paper has a free full text, and the link (identifiers and links only; no full texts downloaded).

  • Not used
    CDE drug trial registry

    Its disclaimer forbids any commercial use of the published information, so it is not used.

  • Not used
    WHO ICTRP

    Its terms of use (4(d)) do not allow the data to be used for marketing, promotional or commercial purposes, so it is not used.

  • Not used
    Wanfang Med

    Human-verification page on the second request.

  • Not used
    NSFC grants

    Its robots.txt disallows automated access.

Known gaps and checks
  • Only PubMed-indexed Chinese-language papers are counted. Most Chinese journals are missing, so provincial hospitals are undercounted.
  • ChiCTR lists trials that are not on ClinicalTrials.gov: none of the 10 IgG4-RD records we read appeared there.
  • 1404 senior-author name spellings appear at two or more hospitals. We show institutions only, not people.
  • Of the 1604 hospitals listed, 399 could be linked to an OpenAlex institution. 277 of those matched a hospital-level ROR record; the other 122 are filed under their university in OpenAlex. OpenAlex and ROR matching for newly added hospitals is pending.
  • Doctors move. New papers show it only months later.
MeasureNPCESCCHCCStomach cancerHepatoblastomaRetinoblastomaChordomaOsteosarcomaGastrointestinal stromal tumourNeuroblastomaEwing sarcomaMyelomaB-ALLAplastic anaemiaHLHBeta thalassaemiaHaemophilia AAtypical haemolytic uraemic syndromeThrombotic thrombocytopenic purpuraFanconi anaemiaNMOSDIgG4-RDMyasthenia gravisMoyamoyaWilson diseaseBiliary atresiaAnti-NMDA receptor encephalitisTakayasu arteritisHepatic echinococcosisIdiopathic pulmonary fibrosisLymphangioleiomyomatosisAmyotrophic lateral sclerosisSpinal muscular atrophyFabry diseasePompe diseaseDuchenne muscular dystrophyBehçet diseaseAlport syndromeIgA nephropathyGaucher diseaseNiemann–Pick disease type COsteogenesis imperfectaPrimary biliary cholangitisPrimary sclerosing cholangitisCongenital diaphragmatic herniaHirschsprung diseaseInherited epidermolysis bullosaHereditary angioedemaFamilial adenomatous polyposisLeber hereditary optic neuropathyMajeed syndromeNGLY1 deficiencyISG15 deficiency
PubMed papers, world3,2684,34928,69521,0694481,1115525,2021,7024,2871,1139,2041,0971,5861,6131,7352,8444317694391,8701,1892,2531,2346877587438044523,9152456,3285608633922,3801,3033601,7315072637721,0069831,109751786568664315276818
with a mainland-China author2,4742,98815,16210,3521653091112,3295641,1691842,0562535074753913093278764962755203602332232752041671,028508076397372412607476739171093321156017160366756523
of which in Chinese996539757011867241372138028957679375148112921432911171539528824728151631911032150104484200
Matched to a named hospital92%93%85%91%92%89%97%91%96%75%92%91%92%91%97%87%85%84%92%78%95%95%94%97%88%92%95%96%90%80%92%76%78%90%64%82%95%99%94%76%53%81%93%86%89%90%87%90%85%93%100%33%67%
No identifiable institution2%2%5%4%1%4%2%4%2%7%4%4%2%5%2%6%3%3%3%8%2%1%4%1%6%2%2%0%8%5%0%5%11%6%19%5%2%0%2%5%6%2%4%3%7%4%5%0%4%2%0%0%33%
Lead authors listing 2+ hospitals7%6%7%5%3%5%6%5%4%4%4%3%5%4%4%6%5%–3%4%7%3%4%7%6%7%7%3%7%5%4%6%2%1%6%8%5%2%5%4%–4%4%5%7%4%2%–7%11%–––
ClinicalTrials.gov studies, world1,1381,0394,0624,38365125674113636482944,0601,572517125300643426783190783556784811979165844898129725516048813439242173398319514088721531688633040
with a site in China5965671,4651,462101365874421648625397484782762784392331620625271255301492017611812225061121635000
Sponsor named only a university2641433403322705963292274100001135000001020002111410020000001000
credited to a hospital with one China site1981042432371502862232264100001132000001000002011110020000001000
OpenAlex works not in PubMed1,0941,1734,6753,257–––––––1,173217275138–––––9263187766047–––––––––––––––––––––––––––
Before contacting a hospital

The same for every disease, so it is kept here; each disease page links to it.

How to start

  1. Talk with the treating doctorWhether a consultation in China would add anything, and whether long-distance travel is advisable, is best discussed first with the doctor who knows the case.
  2. Prepare medical recordsHospitals usually ask for recent reports, scans and pathology before they reply. They quote costs only after seeing them.
  3. Ask 2–3 hospitalsWrite to their international offices. Each hospital page has a bilingual enquiry letter you can copy and a Chinese name card to show staff.

Before asking about a trial: questions to check

From the registered criteria

  • Is the diagnosis confirmed (pathology or other tests the trial names)?
  • Stage or severity, as the trial defines it.
  • Earlier treatment: which drugs or procedures, how many lines, and when the last one ended.
  • Day-to-day activity level (often scored as ECOG or Karnofsky).
  • Recent blood tests: blood counts, liver and kidney function.
  • Recent scans, and whether a measurable lesion is required.
  • Age range and sex.
  • Other conditions the trial excludes, such as hepatitis B or C, HIV, or another cancer.
  • Pregnancy, breastfeeding and contraception rules.

To ask the study team

  • Does the trial accept participants who are not Chinese citizens or residents?
  • In which language are the consent form and questionnaires, and is interpretation provided?
  • How many visits, over how long, and how long a stay in China is needed?
  • Which costs the trial covers and which are paid separately.
  • Whether the visa or permitted stay covers the visit schedule.
  • Which records, scans and pathology slides the team needs, and whether they must be translated.

A reading aid only: this site has no form and stores nothing. Meeting the written criteria is not enough; the study team decides after its own screening tests, usually at the hospital.

Common questions

Do hospitals accept international patients?

Each hospital decides after reviewing the medical records. Many large hospitals have an international department.

How are costs set?

Hospitals quote after reviewing records, and prices depend on the treatment. We do not publish estimates.

Can international patients join trials in China?

Each trial sets its own criteria, and many involve regular visits over several months. Eligibility is decided by the trial team; the contact is on each trial's ClinicalTrials.gov page.

Is a visa needed?

Requirements depend on nationality and length of stay; the local Chinese embassy or consulate can confirm them. We do not arrange visas.

Does more research mean better care?

No. It shows which teams work in this area, not the quality of their care or whether they accept a given patient.

Download the data

All tables as of 2026-11-08. They are derived counts; follow the record links for the underlying papers and trials.

Suggest a correction

Tell us when a fact is out of date or wrong: an institution's name, a broken official link, or a paper or trial credited to the wrong place. We check each one against a public source before changing anything.

Please do not send patient stories, reviews, treatment results or any health information. We do not collect it and will delete it.

Page address:
What it says now:
What it should say:
Public source that shows this (link):

Send to: contact@rayknow.com

Independence

We aggregate public sources. Whether a hospital is listed, and in what order, depends only on public records and the written rules on this page.

Updates

One script (run_pipeline.py) downloads, matches and rebuilds every page and stamps the run date. "Official links last checked" is the date a person last opened those links.